[What’s new in pediatric dermatology?]

J-Ph Lacour1

  • 1Service de dermatologie, Hôpital Archet-2, CS 23079, 06202 Nice, Cedex 3, France.

Insights

This review highlights key 2012-2013 pediatric dermatology advances, focusing on infantile hemangiomas treated with propranolol and new insights into vascular malformations. It also covers atopic dermatitis, congenital nevi, childhood melanoma, and common pediatric skin conditions.

Area of Science:

  • Pediatric Dermatology
  • Dermatopathology
  • Genetics

Context:

  • Review of significant pediatric dermatology literature published October 2012 - October 2013.
  • Focus on advancements in vascular anomalies, atopic dermatitis, and pediatric skin tumors.
  • Incorporates genetic and clinical progress in understanding pediatric dermatoses.

Purpose:

  • To synthesize major developments in pediatric dermatology over a one-year period.
  • To provide an overview of current research trends and clinical insights.
  • To highlight significant findings in vascular anomalies, inflammatory conditions, and neoplasms.

Summary:

  • Propranolol continues to be a key treatment for infantile hemangiomas.
  • Advances in genetics are refining the understanding of vascular malformations and congenital nevi.
  • New epidemiological and pathophysiological data are emerging for atopic dermatitis.
  • Childhood melanoma, though rare, shows an increasing incidence and unique clinical features.
  • The review also touches upon infectious skin diseases, morphea, neurofibromatosis type 1, and psoriasis in children.

Impact:

  • Provides a concise summary of critical updates in pediatric skin health.
  • Informs clinicians and researchers about the latest trends and discoveries.
  • Facilitates evidence-based practice and future research directions in pediatric dermatology.

Related Concept Videos

Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
3.6K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.4K